Pharmanutra S.p.A. Return on Equity (ROE) for the year ending December 31, 2024: 26.72%

Pharmanutra S.p.A. Return on Equity (ROE) is 26.72% for the year ending December 31, 2024, a 13.28% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Pharmanutra S.p.A. Return on Equity (ROE) for the year ending December 31, 2023 was 23.59%, a -20.15% change year over year.
  • Pharmanutra S.p.A. Return on Equity (ROE) for the year ending December 31, 2022 was 29.54%, a -3.31% change year over year.
  • Pharmanutra S.p.A. Return on Equity (ROE) for the year ending December 31, 2021 was 30.55%, a -18.10% change year over year.
  • Pharmanutra S.p.A. Return on Equity (ROE) for the year ending December 31, 2020 was 37.30%, a 24.12% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share